Memphasys (MEM.AX) Stock Price

Memphasys Price

ASX·CLOSED
0.00
​
Market closed

Revenue at Memphasys has contracted by 5.4% per year over the past 19 years to 273,793.00 AUD. Memphasys's net margin stands at -1,498.7%, up from -7,668.9% several years earlier.

Memphasys stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Memphasys business model & stock analysis

Memphasys Ltd, listed on the Australian Securities Exchange under the ticker MEM.AX, is a life sciences company headquartered in Homebush West, New South Wales. The company went public via an IPO on May 14, 2007. Memphasys operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company focuses on developing medical devices, diagnostics, and media for applications in assisted reproduction technology (ART) for both humans and animals. Its product pipeline includes several developments, such as Felix, ROSA, and AI-Port. Felix is a patented, automated device designed to separate high-quality sperm from semen for human in vitro fertilization (IVF) procedures, aiming to avoid DNA damage. ROSA functions as an in vitro diagnostic tool to evaluate semen and blood samples for oxidative stress. AI-Port is a system for storing and transporting animal semen for artificial insemination (AI) in livestock, capable of maintaining semen viability for up to four days without freezing, which is a common practice in standard AI procedures. The company's products target global markets, particularly in the field of reproductive biotechnology, with specific applications in both human and animal reproductive health. Memphasys operates with a focus on innovation in reproductive technology, leveraging proprietary media and diagnostic tools to address challenges in assisted reproduction.

Frequently asked questions about Memphasys

Converted at the current exchange rate, the Memphasys share trades at 0.00 EUR (0.00 AUD).

The Memphasys share (MEM.AX) is listed on 3 stock exchanges, including: ASX (MEM.AX), Frankfurt (IG7.F), München (IG7.MU).

The revenue of Memphasys is 273,793.00 AUD. This figure is based on current financial data and reflects the company's business performance.

The profit of Memphasys is -4.10 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Memphasys is currently -3.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Memphasys stock.

The price-to-sales ratio (P/S) of Memphasys is currently 45.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Memphasys stock.

The Eulerpool Quality Score for Memphasys is 4/10.

The ISIN of Memphasys is AU000000MEM5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Memphasys is A2ANGR. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Memphasys is MEM.AX. The ticker symbol is used to trade Memphasys shares on the stock exchange.

Fair ValueTerminal
0.00 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
May 14, 2007
ISIN
AU000000MEM5
Cusip
Q59718108
Market capitalization
14.09 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
3.34
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-48.52 %
Last updated Oct 18, 2026, 10:36 PM

Memphasys Peer Group

Memphasys Ticker

ASX · MEM.AXFRANKFURT · IG7.FMUNICH · IG7.MU

Memphasys FIGI

IG7:GR · BBG000F31VM2IG7:GF · BBG000F31VS6IG7:GS · BBG000F31XX6IG7:GM · BBG000F31YQ2IG7:GB · BBG000F31ZP0MEM:AU · BBG000QRTHS2MEM:AT · BBG000QRTJ80MEM:AH · BBG002F3MPG5MPHSF:US · BBG00R8DSK62MPHSF:PQ · BBG00R8DSKM4MPHSF:UV · BBG00R8DSKN3IG7:TH · BBG00TP9PPK4

All fundamentals and in-depth analysis of Memphasys

Our stock analysis for Memphasys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Memphasys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.